Malignant Thoracic Neoplasm — Trials

Malignant Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,775
Recruiting: 1,497
Ph III recruiting: 183
Growth YoY: +6.5%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,528)

clinicaltrialsPublishedShowing 301–350 of 795 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07699328	A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer(REACH-EGFR)	recruiting	Phase 1 / Phase 2	315	Voronoi, IncINDUSTRY	10	Jul 13, 2026	clinicaltrials
NCT05077527	Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma	recruiting	Phase 1	20	AIDS Malignancy ConsortiumNETWORK	1	Jul 10, 2026	clinicaltrials